"based on past experience, IMHO, we will not see any major announcements at these events."

Last year they webcast from the Rodman and Renshaw. If they webcast from R&R this year, it would be the first webcast of the year (assuming no other webcast between now and R&R in mid September). There are some items related to clinical trials that we could be updated on. BETonMACE futility analysis, revisions to BETonMACE protocol to allow US patients, and start of renal trial (currently listed as 9/15/17). So not impossible to hear about something new. Whether it is a "major" announcement, we'll have to wait and see.

One more event added today.....October BIO Investor Forum

Aug. 26-30, ESC Congress 2017, Barcelona, Spain: Managing Diabetes & CVD: Is epigenetics a new way forward?

Sep. 10-12, Rodman & Renshaw 19th Annual Global Investment Conference, New York, NY.

Sep. 26-28, BioPharm America 2017, Boston, MA.

Oct. 17-18: BIO Investor Forum 2017, San Francisco, CA.